Abstract
The Sri Lankan Journal of Infectious Diseases (SLJID) is an open access, peer-reviewed, biannual journal published by the Sri Lankan Society for Microbiology (SSM). The Journal considers articles from all professional disciplines involved in the field of infectious diseases. The Journal has been in publication since 2011, is included in the DOAJ since 2018 and is a member of COPE since 2021. The SLJID practices a double-blind peer review policy. From 2022, the SLJID publishes accepted manuscripts online immediately after copy-editing, enabling rapid dissemination of scientific knowledge. The published articles are subsequently compiled into two issues in April and October. The SLJID does not charge any article processing or publication fee.
Highlights
Rapid identification and isolation of infectious individuals are a key preventive measure during the COVID-19 pandemic
We aimed to evaluate a commercially available rapid antigen test kit, STANDARD Q COVID-19 Ag Test (SD Biosensor, Republic of Korea) which was issued by the medical supplies division of the Ministry of Health since mid-November 2020 to the major hospitals in Sri Lanka and to the regional epidemiologists
We tested 40 newly diagnosed asymptomatic SARS-CoV-2 PCR positive individuals admitted to the Kathankudy and Karadiyanaru COVID intermediate care centers during November 2020, using the Standard Q COVID-19 Ag test kit (SD Biosensor, Republic of Korea)
Summary
Rapid identification and isolation of infectious individuals are a key preventive measure during the COVID-19 pandemic. Real-time reverse transcription polymerase chain reaction (rRT-PCR). Received 8 March 2021 and revised version accepted 29 March 2021. Http://sljol.info/index.php/SLJID Vol 11, No 1, April 2021 assays were used by laboratories around the world to detect SARS-Cov-2 virus which is the causative agent of COVID-19. The cost and availability of rRT-PCR is challenging in many countries. The development of a rapid, cheap and reliable point of care test is considered a major milestone in reducing the impact of the pandemic.[1]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
